The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …

Description

Unlock your potential with The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …, a premium course from renowned authors and industry leaders. Gain expert insights, actionable strategies, and practical tools to advance your skills and achieve success.
Join thousands of learners who trust WSOBox for the best online learning experience. Explore courses from top instructors such as Taylor Welch, Jim Camp, Marisa Peer, Scott Sonnon, and many more.

This digital seminar is currently on pre-order meaning that the video will not be ready until 10-12 weeks after the program has taken place.

For the first time in over four decades, researchers are returning to examining the therapeutic benefits of mind altering substances, including MDMA (ecstasy), psilocybin (mushrooms), marijuana and LSD.

In the 1970s the study of all psychedelics was criminalized in the US, despite emerging evidence of their medical value. Over the past decade, the Multidisciplinary Association for Psychedelic Research (MAPS) has helped to revive psychedelic research, sponsoring studies across the United States and around the world, including MDMA-assisted therapy for PTSD, and end-of-life anxiety. The results have been very positive, lasting over 72 months of follow-up, with few adverse effects.

Psychedelics may promote a deepening and acceleration of the psychotherapeutic process. During therapy, people often are able to access and find peace with disavowed, “exiled” parts of themselves.

In this workshop recording the founder of MAPS will describe the evolution of psychedelic therapy, the principal investigator of the Phase I and II level trials will discuss outcomes and processes, the PI of the Hopkins psilocybin study terminally ill patients and a marijuana researcher the promises and pitfalls for that substance. The Boston MDMA study team will discuss clinical experiences and applications.

In appropriate therapeutic contexts, psychedelics may prove to be more effective than most conventional treatments, as well as safer and more cost-effective.

1. Identify how the emerging research of MDMA-assisted psychotherapy (MDMA-AP) can be an effective for clients who do not respond to traditional therapies for PTSD.
2. Distinguish how prolonged exposure (PE) therapy can be ineffective for some clients, and recognize how MDMA-AP decrease client dropout rates.
3. Summarize the mechanism of MDMA in the brain and how that relates to the treatment of trauma.
4. Examine the therapeutic benefits of psychedelic substances, including MDMA (ecstasy), psilocybin (mushrooms) and LSD.
5. Identify the positive effects on PTSD symptom severity by the end of the first treatment trial.
6. Discover how psychedelics may promote a deepening and acceleration of the psychotherapeutic process for clients.
7. Evaluate the research regarding phase I & II trials involving MDMA.
8. Evaluate the potential risks of MDMA-AP, including substance abuse and neurocognitive decline.

Evolution of Psychedelic Therapy

• MDMA – ecstasy
• Psilocybin – mushrooms
• LSD

Why Study MDMA-assisted Therapy for PTSD

Clinical Trials

Phase I & II Trials

• Process
• Outcomes
• Potential risks and benefits

PTSD – Boston’s MDMA Study Team

• Clinical experiences
• Applications

IFS + MDMA Research Studies

Integration of MDMA

Therapist-Client Relationship

Keys to Work Safely with Trauma Clients

Questions/Comments

Tag: The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz , Rick Doblin , William Richards , Daniel McQueen , James W. Hopper , Anne St. Goar , Elizabeth Call , Susan Walker , Francis Guerriero & Michael Alpert Review. The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz , Rick Doblin , William Richards , Daniel McQueen , James W. Hopper , Anne St. Goar , Elizabeth Call , Susan Walker , Francis Guerriero & Michael Alpert download. The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz , Rick Doblin , William Richards , Daniel McQueen , James W. Hopper , Anne St. Goar , Elizabeth Call , Susan Walker , Francis Guerriero & Michael Alpert discount.

Why Choose WSOBox for "The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …"?

At WSOBox, we provide a comprehensive collection of over 70,000 online courses from world-renowned authors and industry leaders. The "The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …" course is one of our premium offerings, carefully curated to help you excel in your personal and professional journey.

Learn from Top Authors and Industry Experts:

• Taylor Welch - Business and Marketing Expert
• Jim Camp - World-Class Negotiation Coach
• Marisa Peer - Leading Therapist and Hypnotherapist
• Scott Sonnon - TACFIT Founder and Fitness Expert
• Dan Kennedy, Brian Tracy, Grant Cardone, Tony Robbins, and more...

What Makes eSoundr Unique?

• ✔️ Access to exclusive, hard-to-find courses from famous authors.
• ✔️ Secure, seamless payment process with instant access to your course.
• ✔️ Downloadable content available for offline learning.
• ✔️ Lifetime access to all purchased courses.

About the "The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …" Course:

The "The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …" course offers step-by-step instructions, practical tools, and proven strategies to help you succeed. Learn at your own pace, anytime and anywhere, with lifetime access to the course materials.

How Will I Receive My Course?

After your successful payment, you’ll receive a direct download link to access the "The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress *Pre-Order* – Michael Mithoefer, Bessel Van der Kolk , Richard C. Schwartz …" course. You can also access it anytime through your WSOBox account.

Need Assistance? How Will I Receive My Course?

If you have any questions, feel free to contact us. Our support team is always ready to assist you in making the most out of your learning experience.

Popular Course Categories at WSOBox?

• 💻 Business & Marketing
• 🎤 Self-Development & Coaching
• 🧠 Hypnotherapy & NLP
• 💪 Health & Fitness
• 🎨 Creative Arts & Design
• 💡 Mindset & Personal Growth

Don’t miss the opportunity to enhance your skills with the best courses at WSOBox. Join our community of lifelong learners and start your journey toward success today!